| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S10557-014-6562-5 |
| P698 | PubMed publication ID | 25410138 |
| P50 | author | Christodoulos I. Stefanadis | Q17308889 |
| Theodora Psaltopoulou | Q47251608 | ||
| Andreas Synetos | Q88185346 | ||
| Dimitris Tousoulis | Q90167660 | ||
| Spyridon Papaioannou | Q95938158 | ||
| Emmanuel Androulakis | Q117271846 | ||
| P2093 | author name string | Nikolaos Papageorgiou | |
| Evangelos Oikonomou | |||
| P2860 | cites work | Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial | Q24654699 |
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Targeting NADPH oxidases in vascular pharmacology | Q26863500 | ||
| Endothelial dysfunction: a comprehensive appraisal | Q28195411 | ||
| Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis | Q28286844 | ||
| Homocysteine lowering and cardiovascular events after acute myocardial infarction | Q28301525 | ||
| Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension | Q28301973 | ||
| Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis | Q28477337 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis | Q30952841 | ||
| Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb | Q33568512 | ||
| Pathophysiology and clinical significance of atherosclerotic plaque rupture | Q33643425 | ||
| Tetrahydrobiopterin in cardiovascular health and disease | Q33687812 | ||
| Plant polyphenols as dietary antioxidants in human health and disease | Q33717002 | ||
| Effect of dietary n - 3 polyunsaturated fatty acids on oxidant/antioxidant status in macrosomic offspring of diabetic rats | Q33766111 | ||
| Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages | Q33886293 | ||
| Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial). | Q33914847 | ||
| Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial | Q33940282 | ||
| Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). | Q34021351 | ||
| Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials | Q34076052 | ||
| The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis | Q34122611 | ||
| Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials | Q34154019 | ||
| Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study. | Q34167806 | ||
| Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. | Q34169470 | ||
| TLR4-mediated anti-atherosclerosis mechanisms of angiotensin-converting enzyme inhibitor--fosinopril | Q43870087 | ||
| Prognostic value of coronary vascular endothelial dysfunction | Q44090667 | ||
| Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells | Q44275923 | ||
| Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial | Q44329632 | ||
| Favorable effects of concord grape juice on endothelial function and arterial stiffness in healthy smokers | Q44500544 | ||
| Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia | Q44575027 | ||
| Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers | Q44651973 | ||
| Polyunsaturated fatty acids as antioxidants. | Q44692726 | ||
| Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure. | Q44850216 | ||
| Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes | Q44891450 | ||
| Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation | Q45020438 | ||
| Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study | Q45022423 | ||
| Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk | Q45089790 | ||
| Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production | Q45182495 | ||
| Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice. | Q45930091 | ||
| The protective effects of green tea polyphenols: lipid profile, inflammation, and antioxidant capacity in rats fed an atherogenic diet and dextran sodium sulfate | Q46050657 | ||
| Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study | Q46174552 | ||
| Bradykinin protects against oxidative stress-induced endothelial cell senescence | Q46202040 | ||
| Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA? | Q46309016 | ||
| Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients | Q46388236 | ||
| Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12. | Q46530591 | ||
| AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats | Q46551832 | ||
| How do dietary flavanols improve vascular function? A position paper | Q46688650 | ||
| Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition | Q46743364 | ||
| Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies | Q46899192 | ||
| Anti-inflammatory and antioxidant properties of a new arylidene-thiazolidinedione in macrophages | Q46937584 | ||
| Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia | Q46966231 | ||
| Hypertension and endothelial dysfunction: therapeutic approach. | Q51658124 | ||
| Effect of ingestion of virgin olive oil on human low-density lipoprotein composition. | Q53978711 | ||
| Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. | Q54105323 | ||
| Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress. | Q54629413 | ||
| Endothelial Dysfunction and Atherosclerosis: Focus on Novel Therapeutic Approaches | Q56444829 | ||
| Secondary prevention of coronary artery disease and the choice of the ACE inhibitor why EUROPA and not PEACE | Q57099619 | ||
| 2013 ESC guidelines on the management of stable coronary artery disease | Q57243329 | ||
| Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial | Q57274347 | ||
| Virtual Histology Evaluation of Atherosclerosis Regression During Atorvastatin and Ezetimibe Administration | Q58004709 | ||
| Vitamin C as an antioxidant: evaluation of its role in disease prevention | Q34175262 | ||
| Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial | Q34248508 | ||
| Comparative pharmacology of chemically distinct NADPH oxidase inhibitors | Q34269250 | ||
| Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins | Q34333678 | ||
| Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis | Q34419008 | ||
| Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound | Q34500083 | ||
| Age-related changes in the lipid compositions of rat and human tissues | Q34543676 | ||
| Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial | Q34544977 | ||
| A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study | Q34581883 | ||
| The endothelium and its role in regulating vascular tone | Q34582309 | ||
| Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 | ||
| Improvement in intestinal coenzyme q10 absorption by food intake | Q34658116 | ||
| Biological properties of olive oil phytochemicals. | Q34680438 | ||
| The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. | Q35090741 | ||
| Interrelationship of Free Oxygen Radicals and Endothelial Dysfunction--Modulation by Statins | Q35108787 | ||
| Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia | Q35118290 | ||
| Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention? | Q35167634 | ||
| Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension | Q35642062 | ||
| Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death | Q35745796 | ||
| Physiology of the endothelium | Q35762200 | ||
| Assessing inflammatory status in cardiovascular disease | Q36014020 | ||
| ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trial | Q36087528 | ||
| Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function | Q36159034 | ||
| Impact of thiazolidinedione therapy on atherogenesis | Q36232378 | ||
| Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease | Q36319955 | ||
| Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
| Analysis of antihypertensive effects of statins. | Q36829002 | ||
| The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial | Q36868391 | ||
| Prognostic value of flow-mediated dilatation following myocardial infarction | Q37052298 | ||
| NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities | Q37069952 | ||
| Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function | Q37102837 | ||
| Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis | Q37139261 | ||
| Polyphenols: benefits to the cardiovascular system in health and in aging | Q37286692 | ||
| Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials | Q37333375 | ||
| Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential | Q37391884 | ||
| Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story | Q37411117 | ||
| Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction | Q37453017 | ||
| Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties | Q37466636 | ||
| Nitric oxide mechanisms of nebivolol. | Q37483065 | ||
| Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling | Q37709733 | ||
| Cardiovascular effects of marine omega-3 fatty acids. | Q37773594 | ||
| Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology | Q37788453 | ||
| The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established | Q37859561 | ||
| Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil | Q37907074 | ||
| Tetrahydrobiopterin: biochemistry and pathophysiology | Q37922206 | ||
| Biosynthesis and metabolism of endothelium-derived nitric oxide | Q37925395 | ||
| Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis | Q37958283 | ||
| Pathophysiology of atherosclerosis: the role of inflammation | Q37971961 | ||
| Molecular mechanisms of the cardiovascular protective effects of polyphenols. | Q38039247 | ||
| Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation | Q38947765 | ||
| Mycophenolic acid attenuates the tumour necrosis factor-α-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-κB and ROS pathways | Q39077512 | ||
| Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial | Q39682678 | ||
| Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway. | Q39905504 | ||
| Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. | Q40238396 | ||
| The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease | Q40561664 | ||
| Endothelial nitric oxide and cardiovascular disease | Q40736642 | ||
| Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction | Q41689431 | ||
| CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function | Q42469710 | ||
| Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study | Q42625498 | ||
| Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase | Q42796781 | ||
| The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice | Q42881647 | ||
| The regular consumption of a polyphenol-rich apple does not influence endothelial function: a randomised double-blind trial in hypercholesterolemic adults. | Q42947442 | ||
| Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. | Q43124896 | ||
| Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial | Q43142931 | ||
| Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. | Q43215240 | ||
| The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function | Q43604506 | ||
| Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. | Q43726340 | ||
| DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants | Q43772116 | ||
| Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. | Q43855545 | ||
| P433 | issue | 1 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 75-88 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Cardiovascular Drugs and Therapy | Q2473050 |
| P1476 | title | Oxidative stress and early atherosclerosis: novel antioxidant treatment | |
| P478 | volume | 29 |
| Q52775460 | Antioxidant Properties of Novel Dimers Derived from Natural β-Elemene through Inhibiting H2O2-Induced Apoptosis. |
| Q47102240 | Antioxidant effect of aqueous extract of four plants with therapeutic potential on gynecological diseases; Semen persicae, Leonurus cardiaca, Hedyotis diffusa, and Curcuma zedoaria |
| Q48176124 | CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis. |
| Q26778017 | Diabetic Cardiovascular Disease Induced by Oxidative Stress |
| Q92062942 | Effect of Aqueous Extract and Polyphenol Fraction Derived from Thymus atlanticus Leaves on Acute Hyperlipidemia in the Syrian Golden Hamsters |
| Q38881790 | Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis |
| Q38540416 | Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease |
| Q49908591 | Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance. |
| Q33560682 | Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways |
| Q46628733 | Mitochondrion-Targeted Peptide SS-31 Inhibited Oxidized Low-Density Lipoproteins-Induced Foam Cell Formation through both ROS Scavenging and Inhibition of Cholesterol Influx in RAW264.7 Cells. |
| Q52838221 | Optimization of Extraction Condition of Bee Pollen Using Response Surface Methodology: Correlation between Anti-Melanogenesis, Antioxidant Activity, and Phenolic Content. |
| Q46269480 | Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets. |
| Q28073105 | Phenolic Melatonin-Related Compounds: Their Role as Chemical Protectors against Oxidative Stress |
| Q26801400 | Redox signaling, Nox5 and vascular remodeling in hypertension |
| Q85855993 | Synthesis of 13-β-elemene ester derivatives and evaluation of their antioxidant activity in human umbilical vein endothelial cells |
| Q91523850 | The mechanisms of traditional Chinese medicine underlying the prevention and treatment of atherosclerosis |
| Q93082057 | Yak-Kong Soybean (Glycine max) Fermented by a Novel Pediococcus pentosaceus Inhibits the Oxidative Stress-Induced Monocyte-Endothelial Cell Adhesion |
Search more.